Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...

Use of the long-acting insulin analogs glargine and detemir does not reduce the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus (T1DM), compared with the ...

Objectives: The prevalence, causes, and consequences of nocturnal hypoglycemia as well as detection and prevention strategies are reviewed, including the use of long-acting insulin analogs ...

Our previous studies have shown that ProINS-Tf was converted to active insulin-transferrin (INS-Tf ... negative side effects seen with other INS analogs. In this report, the data show that ...

He undermines his argument, however, by stating that the newer, more expensive insulin analogs (such as Humalog and Novolog) ...

Key drivers include technological advancements and evolving healthcare policies. The global market for short-acting insulin ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

“The health ministry ensures patients get adequate treatment including increased use of an insulin analogue inhibitor,” he said. Dzulkefly had also attached a statement from the ministry in ...

If you've recently received a diagnosis of type 2 diabetes, understanding your treatment options is an important first step.

Akero Therapeutics has a solid cash runway and financial stability to support ongoing trials for its drug candidate. Read ...

In the last century, advances in the field of insulin therapy have brought us closer to the goal of optimal glycaemic control along with a reduction in diabetes-related complications. However ...